This month we are highlighting the first
trial we have ever funded:
Dr. Brady Stein, from Northwestern Memorial Hospital in Chicago is testing
a PDL1 Inhibitor. The trial is looking for a few Myelofibrosis patients (particularly those with CALR). If
you would like more information, Dr. Stein can be reached
In this month's digest we are highlighting
some upcoming events for MPN patients and caregivers.
There is also
an article highlighting some data presented at ASH on Hydroxyurea vs. Interferon.
Finally, some news you can use:
application deadline for our 2017 request for
proposals is Monday, April 3rd.
Once the proposals we receive are reviewed by a committee of MPN researchers, recommendations for funding will be submitted to our Board of Directors. Stay tuned for information about what projects will be funded this year.